-
In a group of smokers who were hospitalized with cardiac symptoms, a combination of 12 weeks of behavior modification counseling plus pharmacotherapy resulted in higher tobacco abstinence rates, lower re-hospitalization rates, and markedly reduced mortality rates compared with usual care over two years of follow-up.
-
IBS-Drug Treatment Pulled, CV Side Effects; Drug Combo Better for Migraine Treatment; Pergolide Off the Market, Heart Disease Risk; Hormone Treatment, Does Timing Matter?; FDA Actions
-
Two recent large studies have looked at the effects of various inhaler combinations on outcomes in patients with COPD.
-
-
That there is a link between inflammation and atherosclerosis is no longer in dispute. Whether modulation of inflammation might change the process of atherosclerosis, or even better, reduce vascular endpoints, remains a challenging question.
-
The FDA has approved aliskiren, the first of a new class of antihypertensive drugs, the oral renin inhibitors.
-
Using a large pharmacy data base, Irish investigators tracked Tamoxifen use and calculated prescription adherence. By 3.5 years after initial dose, approximately 1/3 of patients had discontinued use.
-
Using data from the 2001-2002 National Health and Nutrition Examination Survey (NHANES), Selvin and colleagues analyzed the responses of men over 20 years of age about their experiences with erectile dysfunction (ED).
-
12-lead ECG and lead II rhythm strip obtained from a hospitalized, older adult with the sudden onset of palpitations and a heart rate of 210/minute.
-
Diabetic gastroparesis, delayed gastric emptying associated with diabetes mellitus, may occur in more than 10% of diabetic patients and can be severely symptomatic and refractory to management.